amyloidosis

(redirected from ATTR amyloidosis)
Also found in: Dictionary, Medical, Encyclopedia.
Related to ATTR amyloidosis: Hereditary amyloidosis, familial amyloidosis
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Words related to amyloidosis

a disorder characterized by deposit of amyloid in organs or tissues

References in periodicals archive ?
This strategic restructuring enables streamlined development and an optimized approach to bringing innovative medicines to patients with ATTR amyloidosis and hemophilia around the world, maximizing the commercial opportunities for these programs, said John Maraganore, Ph.
The study involved the investigational RNAi therapeutic patisiran, which is being developed as a treatment for patients with hereditary ATTR amyloidosis with polyneuropathy.
The most common forms of amyloidosis include systemic AL amyloidosis (formerly primary amyloidosis), systemic AA amyloidosis (formerly secondary amyloidosis), systemic wild-type ATTR amyloidosis (formerly age-related or senile systemic amyloidosis), systemic hereditary ATTR amyloidosis (formerly familial amyloid polyneuropathy), and localized AL amyloidosis (Table 1).
Burden had ATTR amyloidosis, a disease that causes the body's immune system to produce abnormal forms of antibodies, and had been treated at New York Presbyterian Hospital.
M2 PHARMA-January 30, 2018-EMA Accepts Alnylam MAA for Patisiran for Treatment of Hereditary ATTR Amyloidosis
Alnylam Pharmaceuticals announced that the European Medicines Agency has accepted the Marketing Authorisation Application and initiated its review for patisiran, an investigational RNAi therapeutic targeting transthyretin for the treatment of hereditary ATTR amyloidosis.